Sodium Pertechnetate Tc 99M

CHEMBL2096641 Phase 4 ได้รับการอนุมัติ Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
185.9 g/mol
LogP
Phase
4

Sodium pertechnetate Tc-99m is a radioactive technetium pertechnetate salt labeled with the metastable gamma-emitting isotope technetium-99m, used for thyroid scintigraphy, brain perfusion studies, Meckel's diverticulum detection, and as a labeling agent for numerous other technetium-99m radiopharmaceuticals. Technetium-99m emits 140 keV gamma rays with a 6-hour half-life ideal for SPECT imaging while delivering relatively low radiation dose to patients. See sodium pertechnetate for complete pharmacological details.

น้ำหนักโมเลกุล

185.8940 g/mol

TPSA

74.30 Ų

ด้านการรักษา

กลไกการออกฤทธิ์

Contains a radioactive isotope that accumulates in specific tissues or organs, enabling detection and imaging of physiological processes or pathological conditions using nuclear medicine techniques.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

กลไก

Contains a radioactive isotope that accumulates in specific tissues or organs, enabling detection and imaging of physiological processes or pathological conditions using nuclear medicine techniques.

SMILES

[O-][99Tc](=O)(=O)=O.[Na+]

InChI

InChI=1S/Na.4O.Tc/q+1;;;;-1;/i;;;;;1+1

Molecular Formula

NaO4Tc

HBD / HBA

- / 4

พันธะที่หมุนได้

0

อะตอมหนัก

6

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

คำถามที่พบบ่อย

Sodium pertechnetate Tc-99m is a radioactive technetium pertechnetate salt labeled with the metastable gamma-emitting isotope technetium-99m, used for thyroid scintigraphy, brain perfusion studies, Meckel's diverticulum detection, and as a labeling agent for numerous other technetium-99m radiopharmaceuticals. Technetium-99m emits 140 keV gamma rays with a 6-hour half-life ideal for SPECT imaging while delivering relatively low radiation dose to patients. See sodium pertechnetate for complete pharmacological details.

Contains a radioactive isotope that accumulates in specific tissues or organs, enabling detection and imaging of physiological processes or pathological conditions using nuclear medicine techniques.

Yes, Sodium Pertechnetate Tc 99M is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL2096641. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 23689036. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

ข้อจำกัดความรับผิดชอบทางการแพทย์

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.